UK launches AI sandbox to optimise medicine safety
The UK is preparing to launch a pioneering AI sandbox designed to explore how artificial intelligence can improve medicine safety and accelerate the development of new treatments. Led by the Medicines and Healthcare products Regulatory Agency (MHRA), the initiative will create a controlled testing environment where researchers, technology firms and regulators can evaluate emerging AI tools. The programme, backed by the government’s Regulatory Innovation Office, aims to address long-standing challenges in drug development and patient safety. By allowing innovators to test AI systems under regulatory oversight, the UK hopes to identify more reliable ways to predict medication-related risks before treatments reach patients. Officials believe the initiative could help reduce adverse drug reactions, which currently lead to approximately 250,000 hospital admissions across the UK each year and place a financial burden of more than £2bn on the NHS. The project is also expected to provide stronger evidence on the effectiveness of AI in supporting regulatory decision-making. UK Health Innovation Minister Preet Gill explained: “The AI revolution is here, and we want our NHS staff to be …








